Both in Biotechnology
Aligos Therapeutics vs Elutia
Over the past year ALGS returned −41.6% and ELUT returned −15.2%; their daily moves had a correlation of 0.12.
ALGS −41.6% ELUT −15.2%Growth of $1, one year, split-adjusted
| Metric | ALGS | ELUT |
|---|---|---|
| Price | $5.62 | $0.7890 |
| Market cap | $35.1M | $34.9M |
| Today | +1.44% | −2.59% |
| 1 month | −18.7% | −10.3% |
| 6 months | −14.3% | −24.9% |
| Year to date | −39.7% | +13.9% |
| 1 year | −42.6% | −20.5% |
| Revenue growth (YoY) | +2778.5% | −11.6% |
| Gross margin | 100.0% | 59.6% |
| Net margin | −5.4% | −315.0% |
| P/E (TTM) | — | 0.7× |
| Price / sales | 1.1× | 2.9× |
| Net cash | $30.3M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 104.4% | 56.8% |
| Short % of float | 14.5% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).